標(biāo)題: Titlebook: Bone Metastases; A translational and Dimitrios Kardamakis,Vassilios Vassiliou,Edward Ch Book 20091st edition Springer Science+Business Med [打印本頁] 作者: Inoculare 時(shí)間: 2025-3-21 18:37
書目名稱Bone Metastases影響因子(影響力)
書目名稱Bone Metastases影響因子(影響力)學(xué)科排名
書目名稱Bone Metastases網(wǎng)絡(luò)公開度
書目名稱Bone Metastases網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Bone Metastases被引頻次
書目名稱Bone Metastases被引頻次學(xué)科排名
書目名稱Bone Metastases年度引用
書目名稱Bone Metastases年度引用學(xué)科排名
書目名稱Bone Metastases讀者反饋
書目名稱Bone Metastases讀者反饋學(xué)科排名
作者: 粗鄙的人 時(shí)間: 2025-3-22 00:15
Springer Science+Business Media B.V. 2009作者: AMITY 時(shí)間: 2025-3-22 02:43
Dimitrios Kardamakis,Vassilios Vassiliou,Edward ChNo similar edition in the market.Covers all aspects of metastatic bone disease.Contributors are expert in the concerned field.Concise information作者: 任命 時(shí)間: 2025-3-22 07:17
Cancer Metastasis - Biology and Treatmenthttp://image.papertrans.cn/b/image/189687.jpg作者: entreat 時(shí)間: 2025-3-22 09:22
Bone Metastases978-1-4020-9819-2Series ISSN 1568-2102 Series E-ISSN 2215-1648 作者: 延期 時(shí)間: 2025-3-22 15:08 作者: 治愈 時(shí)間: 2025-3-22 18:10
https://doi.org/10.1007/978-3-476-05557-6ncidence of bone metastasis is unknown, but it has been estimated that approximately 300,000–400,000 people in the United States die from bone metastasis each year. Bone metastasis can involve any bone but has a predilection for areas of red bone marrow. Bone lesions are characterized as either oste作者: dithiolethione 時(shí)間: 2025-3-22 23:13
Christoph Jürgensen,Antonius Weixlerswitch” is mediated by various molecules deriving from the cancer cell and/or the tumor-associated stroma and is promoted either by oncogene activation or by the physiological response of any cell to the hypoxic stress. The angiogenic switch is governed by the balance between angiogenic inducers and作者: 染色體 時(shí)間: 2025-3-23 04:15
https://doi.org/10.1007/978-3-476-05732-7of the primary tumor, performance status and age of patients, presence of extraosseus metastases, level of tumor markers and extend of skeletal disease. Bone metastases are inevitably associated with considerable morbidity and suffering, and severe complications such as pain, pathological fractures,作者: alliance 時(shí)間: 2025-3-23 07:38
Christoph Jürgensen,Antonius Weixlerher pathways which report on different aspects of the status of bone formation, bone resorption and bone remodelling. Simple assays for these markers in blood and urine have been developed. Markers for both bone resorption and formation have been correlated with the presence of metastatic bone disea作者: 易改變 時(shí)間: 2025-3-23 12:14 作者: Epidural-Space 時(shí)間: 2025-3-23 16:59
https://doi.org/10.1007/978-3-476-03724-4 techniques applied in humans and still is one of the major requests from physicians. Indeed the sensitivity of this technique is such (>90%) that it is superior to any other available imaging method. On the other hand the specificity is rather low and interpretation of scans needs to be carefully e作者: irritation 時(shí)間: 2025-3-23 18:46 作者: 凹室 時(shí)間: 2025-3-23 23:29 作者: 平靜生活 時(shí)間: 2025-3-24 04:06 作者: 畸形 時(shí)間: 2025-3-24 10:19 作者: 恩惠 時(shí)間: 2025-3-24 11:14
Christine Magerski,Christian Steuerwaldatient’s quality of life, reduce pain and decrease the risk of skeletal adverse events like pathological fractures. However, for some patients, these improvements come with a high price when they develop bisphosphonate adverse events. One serious adverse event that has been recently described is ost作者: Budget 時(shí)間: 2025-3-24 16:37 作者: 彈藥 時(shí)間: 2025-3-24 22:37 作者: febrile 時(shí)間: 2025-3-24 23:11
Christine Magerski,Christian Steuerwaldstic (breast and thyroid cancer) or osteoblastic (prostate cancer) activity prevails. Regardless the types of bone lesion, these cancers usually behave indolently and share in common a significant sensitivity to surgical or medical hormone depleting therapies. Such therapeutic strategies are castrat作者: Distribution 時(shí)間: 2025-3-25 06:11 作者: ensemble 時(shí)間: 2025-3-25 09:55 作者: 引起 時(shí)間: 2025-3-25 15:21
Christine Magerski,Christian Steuerwaldl management of patients with bone metastases, especially for patients with metastatic breast, prostate and small cell lung cancer. The therapeutic outcome and response rates are though limited in chemotherapy-resistant tumors such as non small cell lung cancer and melanoma.作者: averse 時(shí)間: 2025-3-25 19:52
Natural History, Prognosis, Clinical Features and Complications of Metastatic Bone Diseaseith symptom clusters that occur in patients with bone metastases before and after treatment. Such symptoms are pain, depression, fatigue, drowsiness, anxiety, shortness of breath, nausea, poor sense of well being and poor appetite.作者: 無所不知 時(shí)間: 2025-3-25 20:37
The Role of Chemotherapy in the Treatment of Bone Metastasesl management of patients with bone metastases, especially for patients with metastatic breast, prostate and small cell lung cancer. The therapeutic outcome and response rates are though limited in chemotherapy-resistant tumors such as non small cell lung cancer and melanoma.作者: FICE 時(shí)間: 2025-3-26 03:33 作者: 慌張 時(shí)間: 2025-3-26 07:01
Christine Magerski,Christian Steuerwaldcommonly pamidronate and zoledronic acid. Risk factors, diagnostic procedures, patient management and prevention will be the main focus of the discussion. In addition, we will review what is known about the pathobiology of this oral cavity complication of bisphosphonate therapy and will identify areas for future research.作者: 切割 時(shí)間: 2025-3-26 10:19
Bertolt Brechts ?soziologische Experimente‘wed as well as a synopsis of the surgical treatment and management for appendicular, pelvic, and vertebral metastasis. Novel approaches to more accurately guide fracture risk prediction radiologically will be presented and the role of emergent surgery discussed.作者: 窒息 時(shí)間: 2025-3-26 15:31 作者: 上釉彩 時(shí)間: 2025-3-26 20:32
Surgical Management of Bone Metastaseswed as well as a synopsis of the surgical treatment and management for appendicular, pelvic, and vertebral metastasis. Novel approaches to more accurately guide fracture risk prediction radiologically will be presented and the role of emergent surgery discussed.作者: STALL 時(shí)間: 2025-3-27 00:24
1568-2102 ation.Bone Metastases: A Translational and Clinical Approach. serves as both an introductory and reference book focusing on the field of metastatic bone disease. Featuring contributions from experts in the field, this volume: ...describes the molecular and cellular mechanisms involved in the formati作者: Inkling 時(shí)間: 2025-3-27 03:02 作者: gait-cycle 時(shí)間: 2025-3-27 06:56 作者: 果核 時(shí)間: 2025-3-27 11:56
Bone Anatomy, Physiology and Functione bone microenvironment. Additionally, the final step of bone metastasis (bone destruction or production) that determines the clinical phenotype of the metastatic foci (osteolytic or osteoblastic metastasis, respectively) is actually mediated by the bone cells under the influence of various factors 作者: Perineum 時(shí)間: 2025-3-27 13:58
Pathophysiology of Bone Metastasesncidence of bone metastasis is unknown, but it has been estimated that approximately 300,000–400,000 people in the United States die from bone metastasis each year. Bone metastasis can involve any bone but has a predilection for areas of red bone marrow. Bone lesions are characterized as either oste作者: Senescent 時(shí)間: 2025-3-27 19:51 作者: amnesia 時(shí)間: 2025-3-28 01:30
Natural History, Prognosis, Clinical Features and Complications of Metastatic Bone Diseaseof the primary tumor, performance status and age of patients, presence of extraosseus metastases, level of tumor markers and extend of skeletal disease. Bone metastases are inevitably associated with considerable morbidity and suffering, and severe complications such as pain, pathological fractures,作者: 會(huì)犯錯(cuò)誤 時(shí)間: 2025-3-28 05:53
Bone Biomarkers in Research and Clinical Practiceher pathways which report on different aspects of the status of bone formation, bone resorption and bone remodelling. Simple assays for these markers in blood and urine have been developed. Markers for both bone resorption and formation have been correlated with the presence of metastatic bone disea作者: 難管 時(shí)間: 2025-3-28 08:25 作者: mutineer 時(shí)間: 2025-3-28 10:29
The Contribution Of Nuclear Medicine In The Diagnosis Of Bone Metastases techniques applied in humans and still is one of the major requests from physicians. Indeed the sensitivity of this technique is such (>90%) that it is superior to any other available imaging method. On the other hand the specificity is rather low and interpretation of scans needs to be carefully e作者: Defiance 時(shí)間: 2025-3-28 17:20
Magnetic Resonance Imaging Of Metastatic Bone Disease or bone scintigraphy, lack either sensitivity or specificity. Computed tomography (CT) is quite sensitive, however, its ability to detect early deposits is limited. FDG {PET – CT} scan detects metastatic bone disease before occurrence of osteoblastic activity. Magnetic resonance imaging (MRI) has b作者: Obverse 時(shí)間: 2025-3-28 20:47
Radiotherapy And Bone Metastasesints of bone metastases increasingly as life expectancy improves with more systemic therapies. Radiotherapy is an effective, often applied, palliative, non-invasive, local treatment modality for bone metastases. In this chapter the authors discuss the history of different fractionation schedules, th作者: 罐里有戒指 時(shí)間: 2025-3-29 00:15 作者: 柏樹 時(shí)間: 2025-3-29 07:06 作者: Tremor 時(shí)間: 2025-3-29 07:53
Biphosphonates in the Treatment of Bone Metastases – Osteonecrosis of the Jawatient’s quality of life, reduce pain and decrease the risk of skeletal adverse events like pathological fractures. However, for some patients, these improvements come with a high price when they develop bisphosphonate adverse events. One serious adverse event that has been recently described is ost作者: 令人發(fā)膩 時(shí)間: 2025-3-29 14:31
Surgical Management of Bone Metastasesients that are at risk for skeletally related events (SREs). This chapter will review the role of surgery in the management of bone metastases and discuss factors that need to be considered prior to surgery. The treatment of pathologic fractures and the evaluation of pre-critical bony lesions will b作者: Dungeon 時(shí)間: 2025-3-29 19:06 作者: FLUSH 時(shí)間: 2025-3-29 21:23 作者: 大炮 時(shí)間: 2025-3-30 03:25
Radionuclide Therapyity and morbidity. Although bone metastases are often clinically silent, some conditions may support bone pain. Therapeutic strategies for pain palliation could include treatments directed at the source of the pain as well as may focus on comprehensive care of patient. Among the different, mostly pa作者: Transfusion 時(shí)間: 2025-3-30 05:20
Bone Anatomy, Physiology and Functionvant to the metastatic process. It begins with a description of the anatomy and histology of normal bone and continues with a detailed discussion on the microscopic and functional characteristics of bone cells and non-cellular matrix. Finally, a discussion on embryological development of bones, comm作者: 嚴(yán)峻考驗(yàn) 時(shí)間: 2025-3-30 10:31
Pathophysiology of Bone Metastasesments. Bone is a frequent site of involvement in patients with prostate cancer, breast cancer and multiple myeloma (MM) because the propensity of these tumors to home to bone and the capacity of bone marrow to support the growth of the tumor. In patients with osteolytic and osteoblastic bone metasta作者: 安心地散步 時(shí)間: 2025-3-30 15:09 作者: Mets552 時(shí)間: 2025-3-30 18:50 作者: aviator 時(shí)間: 2025-3-30 23:03 作者: onlooker 時(shí)間: 2025-3-31 04:54
